Dietary Fiber Modulates the Window of Susceptibility to Clostridioides difficile Infection

Gastroenterology. 2025 Oct;169(5):970-982. doi: 10.1053/j.gastro.2025.04.027. Epub 2025 May 16.

Abstract

Background & aims: Clostridioides difficile epidemiology is rapidly evolving, and understanding the factors that contribute to one's risk of C difficile infection (CDI) is urgently needed. Based on our observations in a dietary intervention study, we hypothesized that fiber modulates susceptibility to C difficile after antibiotic exposure and investigated this using human specimens and murine models.

Methods: To determine whether fiber impacts factors known to mediate colonization resistance against C difficile, we investigated bile acid and microbiota composition in human subjects consuming a low-fiber diet. To directly test the impact of a fiber-free diet on CDI susceptibility, we treated mice with fiber-rich or fiber-free diets and quantified CDI susceptibility after antibiotic use as well as characterized alterations in bile acid and microbiota composition.

Results: A low-fiber diet leads to increased fecal primary conjugated bile acids in humans, including bile acids known to promote C difficile colonization such as taurocholic acid. Using a novel mouse model of CDI, we show that a fiber-free diet leads to prolonged and increased susceptibility to CDI that is associated with alterations in bile acids. We further report long-lasting perturbation to the microbiota, highlighted by depletion of commensals known to promote colonization resistance against C difficile.

Conclusions: Consumption of a low-fiber diet after antibiotic use contributes to a prolonged susceptibility to CDI that corresponds to a perturbation in both microbiota and bile acid composition. These results suggest that in the context of antibiotic treatment, diet is a critical, modifiable risk factor for CDI susceptibility.

Keywords: Bile Acids; Clostridioides difficile; Dietary Fiber; Microbiota.

MeSH terms

  • Adult
  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Bile Acids and Salts / metabolism
  • Clostridioides difficile*
  • Clostridium Infections* / microbiology
  • Clostridium Infections* / prevention & control
  • Dietary Fiber* / administration & dosage
  • Disease Models, Animal
  • Disease Susceptibility
  • Feces / chemistry
  • Feces / microbiology
  • Female
  • Gastrointestinal Microbiome* / drug effects
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Middle Aged

Substances

  • Dietary Fiber
  • Bile Acids and Salts
  • Anti-Bacterial Agents